Transce3nd, LLC Humacyte, Inc. Put Options Transaction History
Transce3nd, LLC
- $237 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HUMA
# of Institutions
170Shares Held
54.4MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$17.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$17.4 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$10.9 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.43MShares$8.51 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$7.31 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $255M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...